Wen-Chien Chou Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2022	Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
2/2021	Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.
1/2021	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML.
3/2020	Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax.
10/2019	Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
6/2019	Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
2/2019	Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
1/2019	Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
11/2018	Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome.
1/2018	GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Chien Chou Research Topics

Disease

31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2006
10	Neoplasms (Cancer) 01/2022 - 03/2004
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 11/2007
5	Leukemia 02/2019 - 07/2005
5	Acute Promyelocytic Leukemia 01/2017 - 03/2004
4	Disease Progression 01/2018 - 02/2014
3	Residual Neoplasm 01/2021 - 01/2012
2	Hematologic Neoplasms (Hematological Malignancy) 03/2022 - 01/2018
2	Multiple Myeloma 03/2022 - 08/2014
2	Lymphoma (Lymphomas) 03/2020 - 01/2007
2	Thrombocytopenia (Thrombopenia) 10/2019 - 07/2012
2	Infections 01/2019 - 12/2012
2	Diabetes Mellitus 01/2018 - 01/2015
2	Hepatitis B 01/2018 - 01/2015
2	Shock 05/2015 - 12/2012
1	Plasma Cell Neoplasms 03/2022
1	Osteolysis 03/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2022
1	B-Cell Leukemia (Leukemia, B Cell) 03/2020
1	Cytopenia 03/2020
1	Anemia 10/2019
1	Febrile Neutropenia 10/2019
1	Hepatitis 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2016
1	Hematologic Diseases (Blood Diseases) 11/2016
1	Erectile Dysfunction 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Invasive Fungal Infections 01/2015
1	Carcinogenesis 04/2013
1	Neoplasm Metastasis (Metastasis) 04/2013
1	Neutropenia 07/2012
1	Pathologic Complete Response 03/2011
1	Typhoid Fever (Typhoid) 05/2010
1	Psoas Abscess 05/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2010

Drug/Important Bio-Agent (IBA)

10	Biological ProductsIBA 02/2021 - 04/2010
4	Long Noncoding RNAIBA 02/2021 - 02/2019
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2015
3	ArsenicIBA 07/2005 - 03/2004
2	DecorinIBA 03/2022 - 01/2015
2	Rituximab (Mabthera)FDA Link 02/2022 - 01/2007
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 10/2019
2	gilteritinibIBA 01/2022 - 10/2019
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2015
2	GATA2 Transcription FactorIBA 01/2018 - 02/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 01/2016
2	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 04/2010
2	Pharmaceutical PreparationsIBA 07/2012 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 09/2011
2	NucleophosminIBA 01/2012 - 03/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2005 - 03/2004
1	Collagen Type I (Type I Collagen)IBA 03/2022
1	Bendamustine Hydrochloride FDA Link 02/2022
1	polatuzumab vedotinIBA 02/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	midostaurinIBA 01/2022
1	venetoclaxIBA 03/2020
1	AzolesIBA 03/2020
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	CohesinsIBA 12/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	Azacitidine (5 Azacytidine)FDA Link 10/2017
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 01/2017
1	RNA Splicing FactorsIBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Messenger RNA (mRNA)IBA 11/2015
1	LigandsIBA 01/2015
1	Small Leucine-Rich ProteoglycansIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 12/2014
1	Thalidomide (Thalomid)FDA Link 08/2014
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	Lenalidomide (CC 5013)FDA Link 08/2014
1	Bortezomib (Velcade)FDA Link 08/2014
1	Carrier Proteins (Binding Protein)IBA 02/2014
1	Lipocalin-2IBA 08/2013
1	Galectin 3 (LGALS3)IBA 04/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2012
1	Decitabine FDA Link 07/2012
1	CCAAT-Enhancer-Binding Protein-alphaIBA 09/2011
1	Contrast MediaIBA 03/2011
1	Indicators and Reagents (Reagents)IBA 03/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2010

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Induction Chemotherapy 01/2021 - 04/2009
4	Therapeutics 01/2018 - 01/2005
2	Homologous Transplantation 01/2018 - 12/2012
2	Hematopoietic Stem Cell Transplantation 01/2018 - 11/2016
1	Withholding Treatment 02/2022
1	Immunotherapy 01/2022
1	Duration of Therapy 10/2019
1	Stem Cell Transplantation 01/2019
1	Aftercare (After-Treatment) 11/2018
1	Catheters 05/2015
1	Transplantation 11/2014
1	Central Venous Catheters 12/2012